30 Under 30 Local 2023: Boston

  • 📰 Forbes
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 53%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

ForbesUnder30Local: Boston From the youngest Medicare insurance company founder to the engineer breaking barriers in deaf-blind communication, here are the young people from Boston reshaping biotech, healthcare and venture capital.

, also known as Viv for Your V, is a sustainable period products line, founded by Katie Diasti and started as a class project at Boston College. Using bamboo and sugarcane-derived materials, Viv's pads, liners and tampons are easily biodegradable. Its reusable silicone menstrual cup features a ring stem for effortless insertion and removal. With over $1 million in funding, Viv is available in more than 1,600 retail locations, including Wegmans, Stop & Shop, CVS and Amazon.

Later this year, EternalHealth will be available for residents of Maricopa County in Arizona, which is home to the cities of Phoenix, Mesa, and Scottsdale and, more notably, nearly a million people that qualify for Medicare. To date, eternalHealth has raised $30 million in funding from private investors and is valued at $200 million.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AARP calls out the 25 most costly Medicare Part D drugs ahead of price negotiationsAARP is singling out the 25 most costly drugs under Medicare Part D plans as the government prepares to being negotiating prices with drug companies.
Source: dallasnews - 🏆 18. / 71 Read more »

These 10 medications are likely targets for Medicare price negotiations this fallIt's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.
Source: CNBC - 🏆 12. / 72 Read more »